Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02).

Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02).

Item
http://www.wikidata.org/entity/Q43218128
The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancerThe Feasibility of (18)F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal Cancer.Molecular imaging in cancer treatment.Metabolic positron emission tomography imaging in cancer detection and therapy response.Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinomaThe value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer.Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma.Individualized Radiation Dose Escalation Based on the Decrease in Tumor FDG Uptake and Normal Tissue Constraints Improve Survival in Patients With Esophageal Carcinoma.Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.Impact of PET-CT on primary staging and response control on multimodal treatment of esophageal cancer.PET-guided treatment algorithms in oesophageal cancer: the promise of the near future!18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.Correlation between therapy response assessment using FDG PET/CT and histopathologic tumor regression grade in hepatic metastasis of colorectal carcinoma after neoadjuvant therapy.The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
P2860

Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02).

Item
http://www.wikidata.org/entity/Q43218128
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Limited predictive value of FD ...... lti-center trial (SAKK 75/02).
@en
Limited predictive value of FD ...... prospective multi-center trial
@nl
type
label
Limited predictive value of FD ...... lti-center trial (SAKK 75/02).
@en
Limited predictive value of FD ...... prospective multi-center trial
@nl
prefLabel
Limited predictive value of FD ...... lti-center trial (SAKK 75/02).
@en
Limited predictive value of FD ...... prospective multi-center trial
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Limited predictive value of FD ...... lti-center trial (SAKK 75/02).
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698